Exzeo Group's IPO Performance: Exzeo Group's shares opened flat at $21 during its debut on the New York Stock Exchange, valuing the company at nearly $1.91 billion, despite a trend of strong listings in the insurance sector.
Initial Public Offering Details: The company raised $168 million by selling 8 million shares at the midpoint of its target range of $20 to $22 per share.
Market Context: The U.S. IPO market is rebounding after a slowdown, with the SEC easing listing procedures during a government shutdown, allowing for automatic effectiveness of registration statements.
Company Background: Established in 2012, Exzeo provides software and analytics tools for property and casualty insurers, and its parent company, HCI Group, retains an 81.5% stake post-offering.
Wall Street analysts forecast ARX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ARX is 21.13 USD with a low forecast of 17.00 USD and a high forecast of 36.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
9 Analyst Rating
Wall Street analysts forecast ARX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ARX is 21.13 USD with a low forecast of 17.00 USD and a high forecast of 36.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
7 Buy
2 Hold
0 Sell
Strong Buy
Current: 15.260
Low
17.00
Averages
21.13
High
36.00
Current: 15.260
Low
17.00
Averages
21.13
High
36.00
Goldman Sachs
Robert Cox
Buy
maintain
$20
Al Analysis
2026-01-07
Reason
Goldman Sachs
Robert Cox
Price Target
$20
Al Analysis
2026-01-07
maintain
Buy
Reason
Goldman Sachs analyst Robert Cox raised the firm's price target on Accelerant to $20 from $19.50 and keeps a Buy rating on the shares. In a sector note on Americas Insurance, the firm said it expects "strong and fairly resilient" insurer profitability for the next few years, but added that it believes we are "solidly in the softening phase" of the P&C insurance cycle, which leads to "increased capital supply and competition, which should drive a deceleration in growth/pricing/margins, that we think are broadly underappreciated within Street estimates."
Piper Sandler
Overweight
maintain
$15 -> $18
2026-01-07
Reason
Piper Sandler
Price Target
$15 -> $18
2026-01-07
maintain
Overweight
Reason
Piper Sandler raised the firm's price target on Accelerant to $18 from $15 and keeps an Overweight rating on the shares. The firm still thinks the long-term prospects for the insurance brokers are excellent but in the near term are incrementally less optimistic about the brokers. Further, Piper believes the defensive nature of the sector along with margins around all-time highs make the sector attractive as a defensive play. However, organic growth is decelerating, and the firm expects it will continue to decelerate throughout 2026.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for ARX
Unlock Now
Roth Capital
NULL
to
Buy
initiated
$34
2025-12-19
Reason
Roth Capital
Price Target
$34
2025-12-19
initiated
NULL
to
Buy
Reason
Roth Capital initiated coverage of ARC Resources with a Buy rating and C$34 price target. The firm says the company provides investors a "high-quality" Montney producer with rising liquified natural gas price exposure. ARC offers leading free cash flow yields, and a disciplined capital-return framework, the analyst tells investors in a research note.
UBS
Josh Silverstein
Buy -> Neutral
downgrade
$30
2025-12-12
Reason
UBS
Josh Silverstein
Price Target
$30
2025-12-12
downgrade
Buy -> Neutral
Reason
UBS analyst Josh Silverstein downgraded ARC Resources to Neutral from Buy with an unchanged price target of C$30. The firm downgraded the shares as part of its 2026 North American oil and gas outlook.
About ARX
Accelerant Holdings is engaged in transforming specialty insurance through advanced data analytics, AI-driven insights, and innovation. It operates a data-driven risk exchange that connects selected specialty insurance underwriters (the Sellers on its platform) with risk capital partners (the Buyers on its platform). Its Risk Exchange reduces information asymmetries and operational barriers present in the traditional insurance value chain by leveraging proprietary technology to share actionable high-fidelity data and insights with platform participants. Its segments include Exchange Services, MGA Operations, and Underwriting. The Exchange Services segment is its core business, its Risk Exchange- the Accelerant technology, data ingestion, and agency operations that serve the needs of its members and risk capital partners. Its technology-powered platform addresses these issues by connecting specialty underwriters, typically managing general agents (MGAs), and risk capital partners.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
